Paul A. Lacy

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 4 papers. Top paper: “Comparative efficacy of buparvaquone and imidocarb in inhibiting the in vitro growth of Babesia bovis”.

Comparative efficacy of buparvaquone and imidocarb in inhibiting the in vitro growth of Babesia bovis

Frontiers in Pharmacology(2024)10.3389/fphar.2024.1407548

N/A

0DataRank · unranked

7 citations

Paul A. Lacy, Nicolás F. Villarino, J. Stone Doggett, Michael K. Riscoe, Reginaldo G. Bastos +4 more

The Combination of Buparvaquone and ELQ316 Exhibit a Stronger Effect than ELQ316 and Imidocarb Against Babesia bovis In Vitro

Pharmaceutics(2024)10.3390/pharmaceutics16111402

N/A

0DataRank · unranked

2 citations

Nicolás F. Villarino, Paul A. Lacy, Michael K. Riscoe, J. Stone Doggett, Massaro W. Ueti +3 more

The Combination of Buparvaquone and ELQ316 Exhibits a Stronger Synergistic Effect Compared to the Combination of ELQ316 with Imidocarb, on the Survival of Babesia bovis in In Vitro Cultures

Preprints.org(2024)10.20944/preprints202409.2385.v1

N/A

0DataRank · unranked

0 citations

Nicolás F. Villarino, Paul A. Lacy, Michael K. Riscoe, J. Stone Doggett, Massaro W. Ueti +3 more

Enhanced Anti-Babesia Efficacy of Buparvaquone and Imidocarb When Combined with ELQ-316 In Vitro Culture of Babesia bigemina

Pharmaceuticals(2025)10.3390/ph18020218

N/A

0DataRank · unranked

4 citations

Nicolás F. Villarino, Paul A. Lacy, J. Stone Doggett, Michael K. Riscoe, Carlos E. Suárez +3 more